GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (STU:ZIM) » Definitions » Cyclically Adjusted PS Ratio

Zimmer Biomet Holdings (STU:ZIM) Cyclically Adjusted PS Ratio : 3.09 (As of Apr. 30, 2024)


View and export this data going back to . Start your Free Trial

What is Zimmer Biomet Holdings Cyclically Adjusted PS Ratio?

As of today (2024-04-30), Zimmer Biomet Holdings's current share price is €113.00. Zimmer Biomet Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was €36.56. Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio for today is 3.09.

The historical rank and industry rank for Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio or its related term are showing as below:

STU:ZIM' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.51   Med: 4.03   Max: 5.4
Current: 2.99

During the past years, Zimmer Biomet Holdings's highest Cyclically Adjusted PS Ratio was 5.40. The lowest was 2.51. And the median was 4.03.

STU:ZIM's Cyclically Adjusted PS Ratio is ranked worse than
57.85% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs STU:ZIM: 2.99

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Zimmer Biomet Holdings's adjusted revenue per share data for the three months ended in Dec. 2023 was €8.533. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €36.56 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zimmer Biomet Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zimmer Biomet Holdings Cyclically Adjusted PS Ratio Chart

Zimmer Biomet Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.37 4.38 3.34 3.24 2.99

Zimmer Biomet Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.24 3.23 3.60 2.75 2.99

Competitive Comparison of Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio falls into.



Zimmer Biomet Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=113.00/36.56
=3.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zimmer Biomet Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Zimmer Biomet Holdings's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=8.533/129.4194*129.4194
=8.533

Current CPI (Dec. 2023) = 129.4194.

Zimmer Biomet Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 4.888 99.695 6.345
201406 5.091 100.560 6.552
201409 4.999 100.428 6.442
201412 5.756 99.070 7.519
201503 6.062 99.621 7.875
201506 6.013 100.684 7.729
201509 7.633 100.392 9.840
201512 8.655 99.792 11.225
201603 8.456 100.470 10.892
201606 8.632 101.688 10.986
201609 8.048 101.861 10.225
201612 9.343 101.863 11.871
201703 9.080 102.862 11.424
201706 8.518 103.349 10.667
201709 7.457 104.136 9.268
201712 8.567 104.011 10.660
201803 7.997 105.290 9.830
201806 8.399 106.317 10.224
201809 7.663 106.507 9.312
201812 8.919 105.998 10.890
201903 8.495 107.251 10.251
201906 8.535 108.070 10.221
201909 8.301 108.329 9.917
201912 9.202 108.420 10.984
202003 7.818 108.902 9.291
202006 5.265 108.767 6.265
202009 7.856 109.815 9.258
202012 4.705 109.897 5.541
202103 6.400 111.754 7.412
202106 6.946 114.631 7.842
202109 6.802 115.734 7.606
202112 7.486 117.630 8.236
202203 7.188 121.301 7.669
202206 8.015 125.017 8.297
202209 8.019 125.227 8.287
202212 8.181 125.222 8.455
202303 8.128 127.348 8.260
202306 8.221 128.729 8.265
202309 7.824 129.860 7.797
202312 8.533 129.419 8.533

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zimmer Biomet Holdings  (STU:ZIM) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Zimmer Biomet Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zimmer Biomet Holdings (STU:ZIM) Business Description

Traded in Other Exchanges
Address
345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.